Schroder Investment Management Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.05M Buy
2025
Q1
$2.69M Buy
2024
Q4
$1.49M Buy